Home

“Putting data in context – that’s the beauty of it”	“Putting data in context – that’s the beauty of it”	http://www.nfp72.ch/en/News/Pages/210928-news-nfp72-putting-data-in-context.aspx	Interview: Jacques Schrenzel on the current state of the key technology Whole Genome Sequencing (WGS)and what it can do to combat antibiotic resistance.	9/27/2021 10:00:00 PM	Interview with Jacques Schrenzel
Antibiotic research networking event: the market won’t correct things by itself	Antibiotic research networking event: the market won’t correct things by itself	http://www.nfp72.ch/en/News/Pages/210928-news-nfp72-antibiotic-research.aspx	Research is delivering a large number of innovative approaches for new antibiotics, but only a very small number are being developed to market-readiness.	9/27/2021 10:00:00 PM	Antibiotic research: the market won’t correct things by itself
Completed project: Smaller means faster: diagnostics on a microchip	Completed project: Smaller means faster: diagnostics on a microchip	http://www.nfp72.ch/en/News/Pages/210928-news-nfp72-completed-project-smaller-means-faster-diagnostics-on-a-microchip.aspx	A miniaturized method that works with tiny amounts of bacteria could greatly speed up the diagnosis of antibiotic resistance.	9/27/2021 10:00:00 PM	Smaller means faster: diagnostics on a microchip

The objective of the National Research Programme "Antimicrobial Resistance" (NRP 72) is to contribute to reducing antimicrobial resistance as well as decreasing its negative impact on the therapy of infectious diseases.

Since antimicrobial-resistant bacteria are present in human and animal hosts as well as in the environment, NRP is addressing the issue with a one-health approach.

The overall funding for NFP 72 amounts to CHF 20 million for 5 years of research.

Programme timetable

Events

Sustainable use of antibiotics - A cross-sectoral vision for Switzerland

http://www.nfp72.ch/en/Events/Pages/210924-agenda-nfp72-sustainable-use-of-antibiotics.aspx

3/31/2022 7:00:00 AM

3/31/2022 3:00:00 PM

Modern human and veterinary medicine depends on effective antibiotics. To ensure that they will continue to be available in the future, joint efforts are needed from a wide range of stakeholders.